Pub Date : 2025-10-20DOI: 10.3390/clinpract15100189
Luca Piscitani, Paolo Sipari, Lorenzo Ottavio Di Pietro, Sofia Bussolaro, Maurizio Guido, Ilaria Fantasia
During pregnancy, a series of physiological changes occur in women, particularly affecting the cardiovascular system with significant hemodynamic alterations. Subsequently, this leads to renal adaptations manifesting through variations in glomerular filtration rate. This close interconnection between the heart and kidneys implies that issues arising in one organ will disrupt this fundamental balance, inevitably involving all associated organs. The purpose of this review is to gather all possible nephrological conditions that may arise during pregnancy, as well as pre-existing conditions that may become apparent or worsen during this period. This review describes the natural history, treatment, and impact of these conditions on pregnancy itself. Among the most common conditions are preeclampsia and HELLP syndrome, severe complications characterized by hypertension, proteinuria, and multiorgan damage that require immediate clinical attention. Additionally, women with chronic kidney disease are at higher risk of developing maternal-fetal complications, such as preterm birth and intrauterine growth restriction. Common causes of acute renal failure are also analyzed, including thrombotic microangiopathy, acute fatty liver of pregnancy, acute onset or flare of systemic lupus erythematosus, and catastrophic antiphospholipid antibody syndrome. Given the importance of proper renal function during pregnancy, it is essential to have a thorough understanding of nephrological diseases that may affect this phase of women's lives. This knowledge is crucial for managing these conditions effectively to avoid risks to the survival of both the mother and the newborn.
{"title":"Kidney and Pregnancy: A Comprehensive Review.","authors":"Luca Piscitani, Paolo Sipari, Lorenzo Ottavio Di Pietro, Sofia Bussolaro, Maurizio Guido, Ilaria Fantasia","doi":"10.3390/clinpract15100189","DOIUrl":"10.3390/clinpract15100189","url":null,"abstract":"<p><p>During pregnancy, a series of physiological changes occur in women, particularly affecting the cardiovascular system with significant hemodynamic alterations. Subsequently, this leads to renal adaptations manifesting through variations in glomerular filtration rate. This close interconnection between the heart and kidneys implies that issues arising in one organ will disrupt this fundamental balance, inevitably involving all associated organs. The purpose of this review is to gather all possible nephrological conditions that may arise during pregnancy, as well as pre-existing conditions that may become apparent or worsen during this period. This review describes the natural history, treatment, and impact of these conditions on pregnancy itself. Among the most common conditions are preeclampsia and HELLP syndrome, severe complications characterized by hypertension, proteinuria, and multiorgan damage that require immediate clinical attention. Additionally, women with chronic kidney disease are at higher risk of developing maternal-fetal complications, such as preterm birth and intrauterine growth restriction. Common causes of acute renal failure are also analyzed, including thrombotic microangiopathy, acute fatty liver of pregnancy, acute onset or flare of systemic lupus erythematosus, and catastrophic antiphospholipid antibody syndrome. Given the importance of proper renal function during pregnancy, it is essential to have a thorough understanding of nephrological diseases that may affect this phase of women's lives. This knowledge is crucial for managing these conditions effectively to avoid risks to the survival of both the mother and the newborn.</p>","PeriodicalId":45306,"journal":{"name":"Clinics and Practice","volume":"15 10","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12564829/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145393759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-18DOI: 10.3390/clinpract15100188
Magdalena Lixandru, Maniu Ionela, Florin Grosu
Background/Objectives: Coagulopathy is a common complication of liver cirrhosis, partly due to impaired synthesis of vitamin K-dependent coagulation factors. Despite its frequent use, the efficacy of vitamin K in this setting remains uncertain. This study aimed to evaluate the effect of vitamin K administration on coagulation parameters in patients with cirrhosis. Methods: We performed a retrospective study of 122 cirrhotic patients hospitalized between 2020 and 2024, who received vitamin K for coagulopathy correction. Coagulation and liver function parameters were monitored over time. Results: An early and progressive improvement in INR values was observed, in a subset of patients, following vitamin K administration. INR values across time points were strongly correlated, while only weak associations were observed with bilirubin levels. These findings support a selective therapeutic effect, rather than universal efficacy. Discussion: Despite current guidelines discouraging routine vitamin K use in cirrhosis, our findings suggest that selected patients-particularly those with reversible deficiency-may benefit from supplementation. The observed decrease in INR values supports a targeted, context-based approach rather than empirical management. Conclusions: However, due to the retrospective design and absence of a control group, the observed improvements cannot be conclusively attributed to vitamin K administration. Vitamin K may improve coagulation in cirrhotic patients with reversible deficiency, but its efficacy is not universal. Its use should be individualized and guided by clinical and biochemical context, as part of a broader treatment strategy.
{"title":"Effects of Vitamin K Administration in Correcting Coagulopathy in Patients with Liver Cirrhosis: Retrospective Clinical Study.","authors":"Magdalena Lixandru, Maniu Ionela, Florin Grosu","doi":"10.3390/clinpract15100188","DOIUrl":"10.3390/clinpract15100188","url":null,"abstract":"<p><p><b>Background/Objectives:</b> Coagulopathy is a common complication of liver cirrhosis, partly due to impaired synthesis of vitamin K-dependent coagulation factors. Despite its frequent use, the efficacy of vitamin K in this setting remains uncertain. This study aimed to evaluate the effect of vitamin K administration on coagulation parameters in patients with cirrhosis. <b>Methods:</b> We performed a retrospective study of 122 cirrhotic patients hospitalized between 2020 and 2024, who received vitamin K for coagulopathy correction. Coagulation and liver function parameters were monitored over time. <b>Results:</b> An early and progressive improvement in INR values was observed, in a subset of patients, following vitamin K administration. INR values across time points were strongly correlated, while only weak associations were observed with bilirubin levels. These findings support a selective therapeutic effect, rather than universal efficacy. <b>Discussion:</b> Despite current guidelines discouraging routine vitamin K use in cirrhosis, our findings suggest that selected patients-particularly those with reversible deficiency-may benefit from supplementation. The observed decrease in INR values supports a targeted, context-based approach rather than empirical management. <b>Conclusions:</b> However, due to the retrospective design and absence of a control group, the observed improvements cannot be conclusively attributed to vitamin K administration. Vitamin K may improve coagulation in cirrhotic patients with reversible deficiency, but its efficacy is not universal. Its use should be individualized and guided by clinical and biochemical context, as part of a broader treatment strategy.</p>","PeriodicalId":45306,"journal":{"name":"Clinics and Practice","volume":"15 10","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12563240/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145393630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-16DOI: 10.3390/clinpract15100187
Teresa Seoane-Pillado, Roi Suárez-Gil, Sonia Pértega-Díaz, Juan Carlos Piñeiro-Fernández, Elena Rodriguez-Ameijeiras, Emilio Casariego-Vales
Background: The clinical characteristics of patients who have a first episode of congestive heart failure (CHF) may have changed in recent years. Methods: A retrospective cohort study was performed on 19,796 patients discharged from medical departments with a diagnosis of CHF between 1 January 2000 and 31 December 2022. Data were drawn from two data sets of the Minimum Basic Data Set-Hospital Data Set (MBDS) of the Lucus Augusti University Hospital (Spain): hospitalizations and patients. Patient characteristics (including the period of their first admission) and the association rules between diseases determined using the Apriori algorithm were studied in five consecutive time periods. Results: The general characteristics of patients on first admission for CHF changed over time. There were increases in mean age (75.9 ± SD 11.2 vs. 81.6 ± SD 11.5 years; p < 0.0001), the proportion of women (48.3% vs. 51.4; p = 0.0001), the number of acute diseases (1.1 ± SD 1.4 to 2.7 ± SD 2.5; p < 0.0001), and the number of chronic diseases (3.6 ± SD 1.9 to 6.5 ± SD 2.6); p < 0.001). Accordingly, the median number of diagnoses (from 3 to 7) and itemsets per patient increased (mean number of items 1.75 vs. 3.4; p < 0.0001), and the associations of diseases leading to CHF became more complex. Conclusions: This single-center study shows that in the last two decades, the characteristics of patients with a first hospital admission for CHF have changed. Patients are older, there is a predominance of women, and they have a greater number of acute and chronic concomitant diseases, making their clinical management more difficult.
背景:近年来首发充血性心力衰竭(CHF)患者的临床特征可能发生了变化。方法:对2000年1月1日至2022年12月31日期间从内科出院的诊断为CHF的19,796例患者进行回顾性队列研究。数据来自Lucus Augusti大学医院(西班牙)最低基本数据集-医院数据集(MBDS)的两个数据集:住院和患者。患者特征(包括首次入院时间)和使用Apriori算法确定的疾病之间的关联规则在连续五个时间段内进行了研究。结果:首次入院的CHF患者的一般特征随着时间的推移而改变。平均年龄(75.9±SD 11.2岁比81.6±SD 11.5岁,p < 0.0001)、女性比例(48.3%比51.4岁,p = 0.0001)、急性疾病数量(1.1±SD 1.4 ~ 2.7±SD 2.5, p < 0.0001)、慢性疾病数量(3.6±SD 1.9 ~ 6.5±SD 2.6)增加;P < 0.001)。因此,每位患者诊断的中位数(从3到7)和项目集增加(平均项目数1.75 vs. 3.4; p < 0.0001),导致CHF的疾病关联变得更加复杂。结论:这项单中心研究表明,在过去二十年中,首次住院的CHF患者的特征发生了变化。患者年龄较大,以妇女为主,而且他们有更多的急性和慢性伴随疾病,使他们的临床管理更加困难。
{"title":"Temporal Evolution of the Profile of Patients Hospitalized with Heart Failure (2000-2022).","authors":"Teresa Seoane-Pillado, Roi Suárez-Gil, Sonia Pértega-Díaz, Juan Carlos Piñeiro-Fernández, Elena Rodriguez-Ameijeiras, Emilio Casariego-Vales","doi":"10.3390/clinpract15100187","DOIUrl":"10.3390/clinpract15100187","url":null,"abstract":"<p><p><b>Background:</b> The clinical characteristics of patients who have a first episode of congestive heart failure (CHF) may have changed in recent years. <b>Methods:</b> A retrospective cohort study was performed on 19,796 patients discharged from medical departments with a diagnosis of CHF between 1 January 2000 and 31 December 2022. Data were drawn from two data sets of the Minimum Basic Data Set-Hospital Data Set (MBDS) of the Lucus Augusti University Hospital (Spain): hospitalizations and patients. Patient characteristics (including the period of their first admission) and the association rules between diseases determined using the Apriori algorithm were studied in five consecutive time periods. <b>Results:</b> The general characteristics of patients on first admission for CHF changed over time. There were increases in mean age (75.9 ± SD 11.2 vs. 81.6 ± SD 11.5 years; <i>p</i> < 0.0001), the proportion of women (48.3% vs. 51.4; <i>p</i> = 0.0001), the number of acute diseases (1.1 ± SD 1.4 to 2.7 ± SD 2.5; <i>p</i> < 0.0001), and the number of chronic diseases (3.6 ± SD 1.9 to 6.5 ± SD 2.6); <i>p</i> < 0.001). Accordingly, the median number of diagnoses (from 3 to 7) and itemsets per patient increased (mean number of items 1.75 vs. 3.4; <i>p</i> < 0.0001), and the associations of diseases leading to CHF became more complex. <b>Conclusions:</b> This single-center study shows that in the last two decades, the characteristics of patients with a first hospital admission for CHF have changed. Patients are older, there is a predominance of women, and they have a greater number of acute and chronic concomitant diseases, making their clinical management more difficult.</p>","PeriodicalId":45306,"journal":{"name":"Clinics and Practice","volume":"15 10","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12563226/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145393881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Vitamin D deficiency (VDD) is highly prevalent in pediatric critically ill patients and is a potentially modifiable risk factor during critical illness. There are no established national or international recommendations for vitamin D supplementation in Pediatric Intensive Care Unit (PICU) patients.
Objectives: This monocentric study aims to compare the practices regarding vitamin D supplementation before and after the introduction of a nutrition protocol (NP).
Methods: We retrospectively analyzed vitamin D administration (time from PICU admission to initiation, amount of supplementation, accordance with existing guidelines) in children aged 0 to 16 who were admitted to the PICU of Lausanne University Hospital for more than 48 h the year before and the year after the introduction of a NP.
Results: Vitamin D supplementation increased after NP introduction (95 IU per day more, p < 0.0001). More patients received vitamin D during their stay (95% after vs. 77% before, p < 0.0001). The dose adhered to NP recommendations for children under 12 and was higher for older children. According to Swiss guidelines for the general pediatric population, vitamin D supplementation was accurate in children under one year old before and after NP implementation. However, it was less than recommended for patients over one year old.
Conclusions: The implementation of a NP significantly enhanced the scope of vitamin D supplementation. This study also highlights the practical limitations in meeting the recommended requirements with certain galenic formulations.
背景:维生素D缺乏症(VDD)在儿科危重症患者中非常普遍,是危重症期间一个潜在的可改变的危险因素。对于儿科重症监护病房(PICU)患者补充维生素D,目前还没有确定的国家或国际建议。目的:本单中心研究旨在比较在引入营养方案(NP)之前和之后关于维生素D补充的做法。方法:我们回顾性分析了洛桑大学医院PICU在引入NP前一年和引入NP后一年住院超过48小时的0至16岁儿童的维生素D给药情况(从PICU入院到开始使用的时间,补充量,按照现有指南)。结果:引入NP后维生素D的补充增加(每天增加95 IU, p < 0.0001)。更多的患者在住院期间接受维生素D治疗(95%后vs. 77%前,p < 0.0001)。12岁以下儿童的剂量符合NP建议,年龄较大的儿童的剂量更高。根据瑞士对普通儿科人群的指导方针,在NP实施前后,一岁以下儿童补充维生素D是准确的。然而,对于一岁以上的患者,这一数值低于推荐值。结论:NP的实施显著增加了维生素D补充的范围。这项研究还强调了某些盖伦配方在满足推荐要求方面的实际局限性。
{"title":"Impact of a Nutrition Protocol on Vitamin D Supplementation in a Pediatric Intensive Care Unit: A Retrospective Cohort Study.","authors":"Maria Pérez Marin, Vivianne Chanez, Guillaume Maitre, Laurence Boillat, Frida Rizzati, Pauline Lauwers, Maria-Helena Perez","doi":"10.3390/clinpract15100186","DOIUrl":"10.3390/clinpract15100186","url":null,"abstract":"<p><strong>Background: </strong>Vitamin D deficiency (VDD) is highly prevalent in pediatric critically ill patients and is a potentially modifiable risk factor during critical illness. There are no established national or international recommendations for vitamin D supplementation in Pediatric Intensive Care Unit (PICU) patients.</p><p><strong>Objectives: </strong>This monocentric study aims to compare the practices regarding vitamin D supplementation before and after the introduction of a nutrition protocol (NP).</p><p><strong>Methods: </strong>We retrospectively analyzed vitamin D administration (time from PICU admission to initiation, amount of supplementation, accordance with existing guidelines) in children aged 0 to 16 who were admitted to the PICU of Lausanne University Hospital for more than 48 h the year before and the year after the introduction of a NP.</p><p><strong>Results: </strong>Vitamin D supplementation increased after NP introduction (95 IU per day more, <i>p</i> < 0.0001). More patients received vitamin D during their stay (95% after vs. 77% before, <i>p</i> < 0.0001). The dose adhered to NP recommendations for children under 12 and was higher for older children. According to Swiss guidelines for the general pediatric population, vitamin D supplementation was accurate in children under one year old before and after NP implementation. However, it was less than recommended for patients over one year old.</p><p><strong>Conclusions: </strong>The implementation of a NP significantly enhanced the scope of vitamin D supplementation. This study also highlights the practical limitations in meeting the recommended requirements with certain galenic formulations.</p>","PeriodicalId":45306,"journal":{"name":"Clinics and Practice","volume":"15 10","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12563859/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145393815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-06DOI: 10.3390/clinpract15100184
Moisés Árquez-Mendoza, Karen Franco-Valencia, Marco Anaya-Romero, Maria Acevedo-Cerchiaro, Stacey Fragozo-Messino, Deiby Luz Pertuz-Guzman, Jaime Luna-Carrascal
Background: Pediatric asthma is a multifactorial condition influenced by environmental, biological, and social determinants. The COVID-19 pandemic introduced new variables that may have affected the severity and management of asthma in children and adolescents, particularly through changes in healthcare access, treatment adherence, and exposure to environmental risk factors. Objective: To evaluate the association between asthma severity and various factors including nutritional status, corticosteroid use, COVID-19 vaccination, and pollutant exposure before and during the COVID-19 pandemic in a pediatric population. Methods: A retrospective analysis was conducted using 307 medical records of patients aged 3 to 17 years. Data collected included sociodemographic characteristics, nutritional indicators, history of corticosteroid use, vaccination status against COVID-19, and exposure to environmental pollutants. Asthma severity was assessed using the pulmonary score, and multiple statistical analyses, including logistic regression using the Bayesian Logistic Regression Model (BLRM), were employed to identify significant associations. Results: The analysis revealed a statistically significant impact of the pandemic on hospitalization rates (p = 0.0187) and the use of corticosteroids (p = 0.009), indicating changes in asthma management during this period. Notable differences were observed in the geographic distribution of mild versus severe asthma cases prior to the pandemic, associated with nutritional status and gender (p = 0.018). During the pandemic, breastfeeding history, body weight, and hospitalization emerged as significant predictors of asthma severity (p < 0.05). In addition, breastfeeding in young children (aged 3 to 6 years) and hospitalization were strongly associated with pulmonary scores, with significance values of 0.022 and 0.012, respectively, as identified by the BLRM. Conclusions: These findings suggest that the pandemic context influenced both the clinical course and management of pediatric asthma. Preventive strategies should consider individual and environmental factors such as nutrition, early-life health practices (e.g., breastfeeding), and equitable access to appropriate asthma care and vaccination. Tailoring pediatric asthma management to these variables may improve outcomes and reduce disparities in disease severity.
{"title":"Asthma Hospitalizations in Children Before and After COVID-19: Insights from Northern Colombia.","authors":"Moisés Árquez-Mendoza, Karen Franco-Valencia, Marco Anaya-Romero, Maria Acevedo-Cerchiaro, Stacey Fragozo-Messino, Deiby Luz Pertuz-Guzman, Jaime Luna-Carrascal","doi":"10.3390/clinpract15100184","DOIUrl":"10.3390/clinpract15100184","url":null,"abstract":"<p><p><b>Background:</b> Pediatric asthma is a multifactorial condition influenced by environmental, biological, and social determinants. The COVID-19 pandemic introduced new variables that may have affected the severity and management of asthma in children and adolescents, particularly through changes in healthcare access, treatment adherence, and exposure to environmental risk factors. <b>Objective:</b> To evaluate the association between asthma severity and various factors including nutritional status, corticosteroid use, COVID-19 vaccination, and pollutant exposure before and during the COVID-19 pandemic in a pediatric population. <b>Methods:</b> A retrospective analysis was conducted using 307 medical records of patients aged 3 to 17 years. Data collected included sociodemographic characteristics, nutritional indicators, history of corticosteroid use, vaccination status against COVID-19, and exposure to environmental pollutants. Asthma severity was assessed using the pulmonary score, and multiple statistical analyses, including logistic regression using the Bayesian Logistic Regression Model (BLRM), were employed to identify significant associations. <b>Results:</b> The analysis revealed a statistically significant impact of the pandemic on hospitalization rates (<i>p</i> = 0.0187) and the use of corticosteroids (<i>p</i> = 0.009), indicating changes in asthma management during this period. Notable differences were observed in the geographic distribution of mild versus severe asthma cases prior to the pandemic, associated with nutritional status and gender (<i>p</i> = 0.018). During the pandemic, breastfeeding history, body weight, and hospitalization emerged as significant predictors of asthma severity (<i>p</i> < 0.05). In addition, breastfeeding in young children (aged 3 to 6 years) and hospitalization were strongly associated with pulmonary scores, with significance values of 0.022 and 0.012, respectively, as identified by the BLRM. <b>Conclusions:</b> These findings suggest that the pandemic context influenced both the clinical course and management of pediatric asthma. Preventive strategies should consider individual and environmental factors such as nutrition, early-life health practices (e.g., breastfeeding), and equitable access to appropriate asthma care and vaccination. Tailoring pediatric asthma management to these variables may improve outcomes and reduce disparities in disease severity.</p>","PeriodicalId":45306,"journal":{"name":"Clinics and Practice","volume":"15 10","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12562370/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145394000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-06DOI: 10.3390/clinpract15100185
Shoag J Albugami, Rema F AlRasheed, Hussam A Alharbi, Sarah S Alobaid, Hawazin S Alqahtani, Mays N Alharbi, Eyad AlKharashi, Khalid Alhajri
Background: Granulomatous mastitis (GM) is a rare, chronic inflammatory breast condition with poorly understood etiology and variable clinical presentation. The efficacy of corticosteroid therapy in reducing recurrence remains controversial, particularly in Middle Eastern populations where the condition appears more prevalent. This study aimed to describe the demographic and clinical characteristics of patients with GM, evaluate the efficacy of corticosteroid therapy in reducing recurrence rates, and identify risk factors associated with disease recurrence. Methods: A retrospective cohort analysis was conducted on 56 patients diagnosed with GM between 2003 and 2020 at a single tertiary referral center. Patients were stratified into two groups based on steroid use (n = 14 with steroids and n = 42 without steroids). Results: The mean age of the cohort was 46.3 ± 13.2 years, with no significant differences in baseline characteristics between the steroid and non-steroid groups. The most common presentation was a breast mass (32.69%), often associated with abscess formation (25%). Core biopsy was the primary diagnostic tool used (51.79%). Recurrence of GM occurred in 10 patients (18%) overall: 7 patients (17%) in the non-steroid group and 3 patients (21%) in the steroid group. The difference in recurrence rates between the treatment groups was not statistically significant (HR = 1.40, 95% CI:0.30-6.52, p = 0.671). A history of infection (HR = 5.85, 95% CI: 1.60-21.44, p = 0.008) and hormonal disorders (hyperprolactinemia in one patient) (HR = 13.90, 95% CI: 1.43-135.52, p = 0.024) were significantly associated with recurrence. Conclusions: GM remains diagnostically challenging with an 18% recurrence rate in our cohort. We observed no statistically significant reduction in recurrence with corticosteroids, though our analysis was limited by sample size. These findings suggest that targeted management of these conditions may be beneficial in GM patients, though larger multicenter studies are needed to confirm these associations and establish standardized treatment protocols.
{"title":"Corticosteroid Use and Recurrence Risk Factors in Granulomatous Mastitis: A 17-Year Saudi Arabian Cohort Study-Steroids in Granulomatous Mastitis.","authors":"Shoag J Albugami, Rema F AlRasheed, Hussam A Alharbi, Sarah S Alobaid, Hawazin S Alqahtani, Mays N Alharbi, Eyad AlKharashi, Khalid Alhajri","doi":"10.3390/clinpract15100185","DOIUrl":"10.3390/clinpract15100185","url":null,"abstract":"<p><p><b>Background:</b> Granulomatous mastitis (GM) is a rare, chronic inflammatory breast condition with poorly understood etiology and variable clinical presentation. The efficacy of corticosteroid therapy in reducing recurrence remains controversial, particularly in Middle Eastern populations where the condition appears more prevalent. This study aimed to describe the demographic and clinical characteristics of patients with GM, evaluate the efficacy of corticosteroid therapy in reducing recurrence rates, and identify risk factors associated with disease recurrence. <b>Methods:</b> A retrospective cohort analysis was conducted on 56 patients diagnosed with GM between 2003 and 2020 at a single tertiary referral center. Patients were stratified into two groups based on steroid use (n = 14 with steroids and n = 42 without steroids). <b>Results:</b> The mean age of the cohort was 46.3 ± 13.2 years, with no significant differences in baseline characteristics between the steroid and non-steroid groups. The most common presentation was a breast mass (32.69%), often associated with abscess formation (25%). Core biopsy was the primary diagnostic tool used (51.79%). Recurrence of GM occurred in 10 patients (18%) overall: 7 patients (17%) in the non-steroid group and 3 patients (21%) in the steroid group. The difference in recurrence rates between the treatment groups was not statistically significant (HR = 1.40, 95% CI:0.30-6.52, <i>p</i> = 0.671). A history of infection (HR = 5.85, 95% CI: 1.60-21.44, <i>p =</i> 0.008) and hormonal disorders (hyperprolactinemia in one patient) (HR = 13.90, 95% CI: 1.43-135.52, <i>p =</i> 0.024) were significantly associated with recurrence. <b>Conclusions:</b> GM remains diagnostically challenging with an 18% recurrence rate in our cohort. We observed no statistically significant reduction in recurrence with corticosteroids, though our analysis was limited by sample size. These findings suggest that targeted management of these conditions may be beneficial in GM patients, though larger multicenter studies are needed to confirm these associations and establish standardized treatment protocols.</p>","PeriodicalId":45306,"journal":{"name":"Clinics and Practice","volume":"15 10","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12564445/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145393481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background/Objectives: Blood vessel tortuosity can complicate endovascular procedures such as endovascular thrombectomy in acute ischemic stroke. This study aimed to assess the morphometric characteristics of carotid arteries and investigate the association between the tortuosity of the carotid arteries and the technical aspects of endovascular thrombectomy, patient demographics and clinical characteristics, and treatment outcome. Methods: This retrospective study included 84 patients with ischemic stroke treated by endovascular thrombectomy at the newly established thrombectomy-capable stroke center. The following data were collected from prethrombectomy computed tomography angiography: aortic arch type, type of carotid artery tortuosity, and tortuosity index (TI). The technical aspects of the procedure, as well as patient demographics, were collected from the radiological information system. Results: Time from arterial puncture to the first pass was significantly shorter in patients with a nontortuous carotid artery compared to a tortuous one (p = 0.006). There were no significant differences in the number of passes, total duration of the procedure, and the difference in National Institutes of Health Stroke Scale (NIHSS) score before and after the procedure regarding the form of tortuosity. Patients with hypertension had significantly higher tortuosity index values compared to those without hypertension (p = 0.008), and patients with a nontortuous carotid tree were significantly younger compared to those with all forms of tortuosity (p = 0.003). Conclusions: The majority of patients had tortuous carotid arteries, which were associated with older age and hypertension. A high index of tortuosity was associated with a longer time from arterial puncture to the first pass, but not to the treatment outcome. Preprocedural recognition of carotid artery tortuosity may aid in endovascular thrombectomy procedural planning.
{"title":"Impact of Carotid Artery Tortuosity on Technical Aspects of Endovascular Thrombectomy in a Newly Established Thrombectomy-Capable Stroke Center.","authors":"Katja Lovoković, Vjekoslav Kopačin, Mihael Mišir, Mateo Grigić, Domagoj Matijević, Tatjana Rotim, Domagoj Kretić, Damir Štimac, Anja Tomić, Lucija Čolaković, Tajana Turk","doi":"10.3390/clinpract15100183","DOIUrl":"10.3390/clinpract15100183","url":null,"abstract":"<p><p><b>Background/Objectives</b>: Blood vessel tortuosity can complicate endovascular procedures such as endovascular thrombectomy in acute ischemic stroke. This study aimed to assess the morphometric characteristics of carotid arteries and investigate the association between the tortuosity of the carotid arteries and the technical aspects of endovascular thrombectomy, patient demographics and clinical characteristics, and treatment outcome. <b>Methods</b>: This retrospective study included 84 patients with ischemic stroke treated by endovascular thrombectomy at the newly established thrombectomy-capable stroke center. The following data were collected from prethrombectomy computed tomography angiography: aortic arch type, type of carotid artery tortuosity, and tortuosity index (TI). The technical aspects of the procedure, as well as patient demographics, were collected from the radiological information system. <b>Results</b>: Time from arterial puncture to the first pass was significantly shorter in patients with a nontortuous carotid artery compared to a tortuous one (<i>p</i> = 0.006). There were no significant differences in the number of passes, total duration of the procedure, and the difference in National Institutes of Health Stroke Scale (NIHSS) score before and after the procedure regarding the form of tortuosity. Patients with hypertension had significantly higher tortuosity index values compared to those without hypertension (<i>p</i> = 0.008), and patients with a nontortuous carotid tree were significantly younger compared to those with all forms of tortuosity (<i>p</i> = 0.003). <b>Conclusions</b>: The majority of patients had tortuous carotid arteries, which were associated with older age and hypertension. A high index of tortuosity was associated with a longer time from arterial puncture to the first pass, but not to the treatment outcome. Preprocedural recognition of carotid artery tortuosity may aid in endovascular thrombectomy procedural planning.</p>","PeriodicalId":45306,"journal":{"name":"Clinics and Practice","volume":"15 10","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12564570/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145393753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-30DOI: 10.3390/clinpract15100182
Man Hung, Jacob Daniel Gardner, Samantha Lee, Wendy C Birmingham, Richard M Stevens, Connor Schwartz, Nader Karimi, Amir Mohajeri
Introduction: Evidence on orthodontic interventions for temporomandibular disorders (TMD) is fragmented and inconclusive, creating a gap in guidance for clinical decision-making. This study addresses that gap by evaluating current knowledge on these interventions. Methods: A PRISMA-ScR scoping review was conducted with a systematic search of PubMed, Scopus, and Web of Science (2018-2023). Eligible studies were peer-reviewed, English-language, human studies examining TMD treatment and/or etiology. Three independent reviewers screened records and extracted data and a fourth reviewer performed random audits. Results: Of 899 records, 10 studies met inclusion criteria (non-surgical, n = 7: 4 case reports, 2 prospective, 1 longitudinal; combined orthodontic-surgical, n = 3: 1 case report, 2 longitudinal; participant ages 15-71 years). Diagnostics included imaging, clinical examination, occlusal analysis, and questionnaires, although few used RDC/TMD or DC/TMD criteria. Non-surgical orthodontic modalities (fixed appliances, camouflage, TADs, stabilization splints) showed mixed results, with several studies reporting short-term symptom improvement, while others found no effect on TMD onset or progression. Combined orthodontic-surgical approaches (e.g., bilateral sagittal split osteotomy, Le Fort I) also showed variable outcomes. Conclusions: Low-to-moderate quality evidence suggests that orthodontic-surgical interventions may alleviate TMD symptoms in select patients; however, heterogeneity and limited use of standardized diagnostics constrain the certainty of these findings. Future research should prioritize DC/TMD-based diagnostics, core outcomes, comparative designs, and ≥12-24 months of follow-up to identify prognostic factors and responsive subgroups.
关于颞下颌疾病(TMD)正畸干预的证据是碎片化和不确定的,这给临床决策的指导带来了空白。本研究通过评估对这些干预措施的现有知识来解决这一差距。方法:通过系统检索PubMed、Scopus和Web of Science(2018-2023)进行PRISMA-ScR范围综述。符合条件的研究是同行评议的、英语的、检查TMD治疗和/或病因的人类研究。三名独立审查员筛选记录并提取数据,第四名审查员进行随机审核。结果:在899份记录中,有10项研究符合纳入标准(非手术研究,n = 7: 4例报告,2例前瞻性,1例纵向;正畸-外科联合研究,n = 3: 1例报告,2例纵向;参与者年龄15-71岁)。诊断包括影像学、临床检查、咬合分析和问卷调查,尽管很少使用RDC/TMD或DC/TMD标准。非手术正畸方式(固定矫治器、伪装、TADs、稳定夹板)的结果好坏参半,一些研究报告了短期症状改善,而另一些研究发现对TMD的发病或进展没有影响。正畸-外科联合入路(如双侧矢状面劈开截骨术,Le Fort I)也显示出不同的结果。结论:低到中等质量的证据表明,正畸手术干预可以减轻部分患者的TMD症状;然而,异质性和标准化诊断的有限使用限制了这些发现的确定性。未来的研究应优先考虑基于DC/ tmd的诊断、核心结局、比较设计和≥12-24个月的随访,以确定预后因素和反应性亚组。
{"title":"Treating Temporomandibular Disorders Through Orthodontics: A Scoping Review of Evidence, Gaps, and Clinical Guidance.","authors":"Man Hung, Jacob Daniel Gardner, Samantha Lee, Wendy C Birmingham, Richard M Stevens, Connor Schwartz, Nader Karimi, Amir Mohajeri","doi":"10.3390/clinpract15100182","DOIUrl":"10.3390/clinpract15100182","url":null,"abstract":"<p><p><b>Introduction:</b> Evidence on orthodontic interventions for temporomandibular disorders (TMD) is fragmented and inconclusive, creating a gap in guidance for clinical decision-making. This study addresses that gap by evaluating current knowledge on these interventions. <b>Methods:</b> A PRISMA-ScR scoping review was conducted with a systematic search of PubMed, Scopus, and Web of Science (2018-2023). Eligible studies were peer-reviewed, English-language, human studies examining TMD treatment and/or etiology. Three independent reviewers screened records and extracted data and a fourth reviewer performed random audits. <b>Results:</b> Of 899 records, 10 studies met inclusion criteria (non-surgical, <i>n</i> = 7: 4 case reports, 2 prospective, 1 longitudinal; combined orthodontic-surgical, <i>n</i> = 3: 1 case report, 2 longitudinal; participant ages 15-71 years). Diagnostics included imaging, clinical examination, occlusal analysis, and questionnaires, although few used RDC/TMD or DC/TMD criteria. Non-surgical orthodontic modalities (fixed appliances, camouflage, TADs, stabilization splints) showed mixed results, with several studies reporting short-term symptom improvement, while others found no effect on TMD onset or progression. Combined orthodontic-surgical approaches (e.g., bilateral sagittal split osteotomy, Le Fort I) also showed variable outcomes. <b>Conclusions:</b> Low-to-moderate quality evidence suggests that orthodontic-surgical interventions may alleviate TMD symptoms in select patients; however, heterogeneity and limited use of standardized diagnostics constrain the certainty of these findings. Future research should prioritize DC/TMD-based diagnostics, core outcomes, comparative designs, and ≥12-24 months of follow-up to identify prognostic factors and responsive subgroups.</p>","PeriodicalId":45306,"journal":{"name":"Clinics and Practice","volume":"15 10","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12562917/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145393923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-28DOI: 10.3390/clinpract15100179
Elca Silvania da Silva Abreu, Caroline Oliveira Dos Anjos, Zafirah Muhammad Rahman, Renata Miyabara, Ovidiu Constantin Baltatu, Luciana Aparecida Campos
Background/Objectives: Vitamin D deficiency is prevalent in elderly populations and may impact surgical recovery. Despite the equatorial location, vitamin D insufficiency affects many elderly Ribeirinhos in the Brazilian Amazon. This study investigated whether pre-existing vitamin D supplementation influences postoperative outcomes in elderly Ribeirinhos following femur fracture surgery, while examining metabolic parameters and documenting chronic disease prevalence. Methods: This prospective cohort study enrolled 60 elderly Ribeirinhos patients (≥65 years) admitted for femur fracture surgery at the Regional Hospital of Lower Amazon. Twenty-two patients had participated in a vitamin D supplementation program (50,000 IU monthly, 3-6 months) prior to admission; 38 had not. Primary outcomes were hospitalization duration and serum 25-hydroxyvitamin D levels. Secondary outcomes included ionized calcium, blood glucose, and comorbidity documentation. Results: The supplementation group was associated with significantly shorter hospitalization (14.32 ± 0.79 vs. 22.61 ± 0.88 days, p < 0.0001), representing 37% reduction. Vitamin D levels were markedly higher in supplemented patients (50.26 ± 2.55 vs. 21.74 ± 0.84 ng/mL, p < 0.0001). Ionized calcium was elevated in the supplementation group (1.29 ± 0.01 vs. 1.08 ± 0.02 mmol/L, p < 0.001) without hypercalcemia. Blood glucose was lower in supplemented patients (83.8 ± 1.4 vs. 152.2 ± 9.6 mg/dL, p < 0.001). Medical records revealed that 73.3% had hypertension and 31.7% had diabetes, with 25% having both conditions. Conclusions: Pre-existing vitamin D supplementation was associated with reduced hospitalization duration following femur fracture surgery, though causality cannot be inferred due to observational design. Community-based vitamin D programs may warrant further investigation in vulnerable populations, with randomized trials needed.
背景/目的:维生素D缺乏症在老年人群中普遍存在,并可能影响手术恢复。尽管地处赤道地区,维生素D不足仍影响着巴西亚马逊地区许多年长的里贝林霍人。本研究调查了补充维生素D是否会影响老年ribebeinhos股骨骨折手术后的预后,同时检查了代谢参数并记录了慢性疾病的患病率。方法:本前瞻性队列研究纳入60例老年ribebeirinhos患者(≥65岁),在亚马逊河下游地区医院接受股骨骨折手术。22名患者在入院前参加了维生素D补充计划(每月50,000 IU, 3-6个月);38人没有。主要结局是住院时间和血清25-羟基维生素D水平。次要结局包括离子钙、血糖和合并症记录。结果:补充组住院时间明显缩短(14.32±0.79天vs. 22.61±0.88天,p < 0.0001),减少37%。维生素D水平在补充组明显升高(50.26±2.55 vs. 21.74±0.84 ng/mL, p < 0.0001)。在无高钙血症的情况下,添加组的离子钙含量升高(1.29±0.01 vs 1.08±0.02 mmol/L, p < 0.001)。血糖较低(83.8±1.4 vs. 152.2±9.6 mg/dL, p < 0.001)。医疗记录显示,73.3%的人患有高血压,31.7%的人患有糖尿病,25%的人同时患有这两种疾病。结论:预先存在的维生素D补充与股骨骨折手术后住院时间缩短有关,但由于观察性设计,无法推断因果关系。以社区为基础的维生素D项目可能需要在弱势人群中进行进一步的调查,需要进行随机试验。
{"title":"Vitamin D and Postoperative Recovery in Elderly Ribeirinhos-Riverside Amazon Communities with Femur Fractures.","authors":"Elca Silvania da Silva Abreu, Caroline Oliveira Dos Anjos, Zafirah Muhammad Rahman, Renata Miyabara, Ovidiu Constantin Baltatu, Luciana Aparecida Campos","doi":"10.3390/clinpract15100179","DOIUrl":"10.3390/clinpract15100179","url":null,"abstract":"<p><p><b>Background/Objectives</b>: Vitamin D deficiency is prevalent in elderly populations and may impact surgical recovery. Despite the equatorial location, vitamin D insufficiency affects many elderly Ribeirinhos in the Brazilian Amazon. This study investigated whether pre-existing vitamin D supplementation influences postoperative outcomes in elderly Ribeirinhos following femur fracture surgery, while examining metabolic parameters and documenting chronic disease prevalence. <b>Methods</b>: This prospective cohort study enrolled 60 elderly Ribeirinhos patients (≥65 years) admitted for femur fracture surgery at the Regional Hospital of Lower Amazon. Twenty-two patients had participated in a vitamin D supplementation program (50,000 IU monthly, 3-6 months) prior to admission; 38 had not. Primary outcomes were hospitalization duration and serum 25-hydroxyvitamin D levels. Secondary outcomes included ionized calcium, blood glucose, and comorbidity documentation. <b>Results</b>: The supplementation group was associated with significantly shorter hospitalization (14.32 ± 0.79 vs. 22.61 ± 0.88 days, <i>p</i> < 0.0001), representing 37% reduction. Vitamin D levels were markedly higher in supplemented patients (50.26 ± 2.55 vs. 21.74 ± 0.84 ng/mL, <i>p</i> < 0.0001). Ionized calcium was elevated in the supplementation group (1.29 ± 0.01 vs. 1.08 ± 0.02 mmol/L, <i>p</i> < 0.001) without hypercalcemia. Blood glucose was lower in supplemented patients (83.8 ± 1.4 vs. 152.2 ± 9.6 mg/dL, <i>p</i> < 0.001). Medical records revealed that 73.3% had hypertension and 31.7% had diabetes, with 25% having both conditions. <b>Conclusions</b>: Pre-existing vitamin D supplementation was associated with reduced hospitalization duration following femur fracture surgery, though causality cannot be inferred due to observational design. Community-based vitamin D programs may warrant further investigation in vulnerable populations, with randomized trials needed.</p>","PeriodicalId":45306,"journal":{"name":"Clinics and Practice","volume":"15 10","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12562707/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145393908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-28DOI: 10.3390/clinpract15100180
Giacomo Farì, Annatonia Fai, Francesco Quarta, Morena Pitruzzella, Cristiano Sconza, Matteo Luigi Giuseppe Leoni, Giustino Varrassi, Marco Filipponi, Giuseppe Rollo, Alessio Baricich, Andrea Bernetti
Background: Depression affects around 280 million people globally and is one of the main causes of disability. Among people with cancer, depression and anxiety affect 20-25%, significantly reducing quality of life, adherence to treatments, and survival. Despite the availability of pharmacological and psychological treatments, their application can be limited by side effects, accessibility, and costs-especially in low- and middle-income countries. Physical exercise is emerging as a valuable complementary strategy, improving both physical and mental well-being. Nevertheless, structured exercise programs are still rarely implemented in oncology. This review aims to provide evidence-based recommendations for integrating physical activity into mental health support for people with cancer. Methods: This review includes six randomized controlled trials (RCTs) evaluating physical exercise interventions for depression and anxiety in people with cancer aged over 18 years. Included studies compared exercise interventions to control or standard care and reported outcomes related to psychological well-being and adverse effects. Exclusion criteria included non-original studies, non-English articles, and works not focused on exercise. The search was conducted in PubMed, Scopus, Google Scholar, and the Cochrane Library using MeSH terms and Boolean operators. The review protocol was registered in PROSPERO (CRD42025637522). Results: Exercise interventions-such as aerobic, resistance, and mind-body practices-proved effective and feasible across cancer types. Benefits were seen in both psychological and physical outcomes. However, variations in protocols and outcome measures, as well as a lack of long-term data, limit generalizability. Conclusions: Personalized exercise programs can significantly reduce depression and anxiety in people with cancer. Standardized core methods, long-term research, and systemic support are needed to integrate exercise into routine oncology care.
{"title":"The Effects of Physical Exercise on Depression and Anxiety in Cancer Patients: A Systematic Review.","authors":"Giacomo Farì, Annatonia Fai, Francesco Quarta, Morena Pitruzzella, Cristiano Sconza, Matteo Luigi Giuseppe Leoni, Giustino Varrassi, Marco Filipponi, Giuseppe Rollo, Alessio Baricich, Andrea Bernetti","doi":"10.3390/clinpract15100180","DOIUrl":"10.3390/clinpract15100180","url":null,"abstract":"<p><p><b>Background</b>: Depression affects around 280 million people globally and is one of the main causes of disability. Among people with cancer, depression and anxiety affect 20-25%, significantly reducing quality of life, adherence to treatments, and survival. Despite the availability of pharmacological and psychological treatments, their application can be limited by side effects, accessibility, and costs-especially in low- and middle-income countries. Physical exercise is emerging as a valuable complementary strategy, improving both physical and mental well-being. Nevertheless, structured exercise programs are still rarely implemented in oncology. This review aims to provide evidence-based recommendations for integrating physical activity into mental health support for people with cancer. <b>Methods</b>: This review includes six randomized controlled trials (RCTs) evaluating physical exercise interventions for depression and anxiety in people with cancer aged over 18 years. Included studies compared exercise interventions to control or standard care and reported outcomes related to psychological well-being and adverse effects. Exclusion criteria included non-original studies, non-English articles, and works not focused on exercise. The search was conducted in PubMed, Scopus, Google Scholar, and the Cochrane Library using MeSH terms and Boolean operators. The review protocol was registered in PROSPERO (CRD42025637522). <b>Results</b>: Exercise interventions-such as aerobic, resistance, and mind-body practices-proved effective and feasible across cancer types. Benefits were seen in both psychological and physical outcomes. However, variations in protocols and outcome measures, as well as a lack of long-term data, limit generalizability. <b>Conclusions</b>: Personalized exercise programs can significantly reduce depression and anxiety in people with cancer. Standardized core methods, long-term research, and systemic support are needed to integrate exercise into routine oncology care.</p>","PeriodicalId":45306,"journal":{"name":"Clinics and Practice","volume":"15 10","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12563091/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145393917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}